Clinical Trial

Reducing Disparities in Knee Arthroscopy for Adolescents

Study acronym: RED KARD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Hundreds of thousands of youth athletes require surgery for knee injuries annually. The incidence of operative knee injuries has skyrocketed, but surgery can be delayed due to late recognition and barriers, such as insurance, language, and difficulty navigating the healthcare system. Delays may have lifelong effects, including arthritis, persistent instability, poor patient reported outcomes, and reoperation. There is little patient-centered research on barriers to orthopaedic care, and none on interventions to reduce disparities in pediatric sports medicine. This study will focus on Hispanic children, a growing population nationally and 38% of the Chicago's children, who are at increased risk of delayed knee surgery and its sequelae compared to white, non-Hispanic patients. The overall objectives are to identify barriers to timely knee surgery in Hispanic athletes and develop an intervention to implement evidence on expedient treatment. The aim of this study is to evaluate feasibility, acceptability, and appropriateness of a culturally-tailored intervention in a pilot study of Hispanic youth soccer leagues. The proposed study will drive creation of a future community trial of a culturally-tailored intervention.
Protocol Amendment History 6 changes
critical Trial status changed: Recruiting → Not Yet Recruiting 2026-06-19
critical Phase changed: not specified -> not applicable 2026-06-19
critical Primary endpoint(s) modified 2026-06-19
minor Trial arms changed: 0 -> 2 2026-06-19
notable Primary completion pushed: 2026-12 -> 2029-06 2026-06-19
minor Completion pushed: 2027-05 -> 2029-07 2026-06-19
Trial Details
NCT Number NCT07580625
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Knee Injury, ACL Injury, Meniscus Tear, Hispanic or Latino, Adolescent
Enrollment 80 participants
Start Date 2027-10-01
Primary Completion 2029-06 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-18